BACKGROUND: The breast cancer (BC) and its treatment (mastectomy, radiotherapy, and chemotherapy) have considerable psychosexual impacts on women's life. This study evaluated sexual functioning, quality of life, and self-esteem in young women with early-stage BC. METHODS: A total of 186 women with stage I or II BC and 204 age-matched controls aged 25-45 years were recruited. To be eligible, patients had to be disease-free and sexually active. They also had to have undergone lumpectomy at least 1 year previously and have completed chemotherapy and/or radiotherapy. Subjects completed Female Sexual Function Index, Short Form-36 Health Survey, and Rosenberg Self-Esteem questionnaire. Serum sex hormones were also measured in all subjects. RESULTS: Of BC patients, 57% experienced lubrication disorder followed by satisfaction disorder in 53.8%, desire disorder in 42.5%, and arousal disorder in 37.0% (all patients vs. healthy controls <0.01). Hormone-treated patients were more likely to report sexual dysfunctions (p = 0.006). The radiotherapy + chemotherapy + hormone therapy was associated with an about sixfold increased risk of lubrication and satisfaction disorders (adjusted odds ratios = 6.4, 95%CI = 4.6-12.6, and adjusted odds ratios = 5.7, 95%CI = 3.4-11.4, respectively). Cancer patients had lower scores for all components of the Short Form-36 Health Survey, except for pain. Levels of self-esteem did not differ significantly between the two groups. CONCLUSIONS: Young lumpectomized BC women reported a marked impairment in sexual functioning and quality of life.
BACKGROUND: The breast cancer (BC) and its treatment (mastectomy, radiotherapy, and chemotherapy) have considerable psychosexual impacts on women's life. This study evaluated sexual functioning, quality of life, and self-esteem in young women with early-stage BC. METHODS: A total of 186 women with stage I or II BC and 204 age-matched controls aged 25-45 years were recruited. To be eligible, patients had to be disease-free and sexually active. They also had to have undergone lumpectomy at least 1 year previously and have completed chemotherapy and/or radiotherapy. Subjects completed Female Sexual Function Index, Short Form-36 Health Survey, and Rosenberg Self-Esteem questionnaire. Serum sex hormones were also measured in all subjects. RESULTS: Of BC patients, 57% experienced lubrication disorder followed by satisfaction disorder in 53.8%, desire disorder in 42.5%, and arousal disorder in 37.0% (all patients vs. healthy controls <0.01). Hormone-treated patients were more likely to report sexual dysfunctions (p = 0.006). The radiotherapy + chemotherapy + hormone therapy was associated with an about sixfold increased risk of lubrication and satisfaction disorders (adjusted odds ratios = 6.4, 95%CI = 4.6-12.6, and adjusted odds ratios = 5.7, 95%CI = 3.4-11.4, respectively). Cancerpatients had lower scores for all components of the Short Form-36 Health Survey, except for pain. Levels of self-esteem did not differ significantly between the two groups. CONCLUSIONS: Young lumpectomized BC women reported a marked impairment in sexual functioning and quality of life.
Authors: Jennifer Barsky Reese; Kristen Sorice; Stephen J Lepore; Mary B Daly; James A Tulsky; Mary Catherine Beach Journal: Patient Educ Couns Date: 2018-10-04
Authors: Caroline S Dorfman; Sarah S Arthur; Gretchen G Kimmick; Kelly W Westbrook; Paul Kelly Marcom; Cheyenne Corbett; Sara N Edmond; Rebecca A Shelby Journal: Menopause Date: 2019-08 Impact factor: 2.953
Authors: Jennifer Barsky Reese; Mary Catherine Beach; Katherine Clegg Smith; Elissa T Bantug; Kristen E Casale; Laura S Porter; Sharon L Bober; James A Tulsky; Mary B Daly; Stephen J Lepore Journal: Support Care Cancer Date: 2017-04-27 Impact factor: 3.603
Authors: H Irene Su; Shaylyn Stark; Brian Kwan; Sarah Boles; Diana Chingos; Jennifer Ehren; Jessica R Gorman; Michael Krychman; Sally A D Romero; Jun J Mao; John P Pierce; Loki Natarajan Journal: Breast Cancer Res Treat Date: 2019-05-03 Impact factor: 4.872
Authors: Jennifer Barsky Reese; Laura S Porter; Kristen E Casale; Elissa T Bantug; Sharon L Bober; Sharon C Schwartz; Katherine Clegg Smith Journal: Health Psychol Date: 2016-08-15 Impact factor: 4.267
Authors: Victoria L Champion; Lynne I Wagner; Patrick O Monahan; Joanne Daggy; Lisa Smith; Andrea Cohee; Kim W Ziner; Joan E Haase; Kathy D Miller; Kamnesh Pradhan; Frederick W Unverzagt; David Cella; Bilal Ansari; George W Sledge Journal: Cancer Date: 2014-05-28 Impact factor: 6.860
Authors: Maria Ida Maiorino; Paolo Chiodini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito Journal: Endocrine Date: 2015-12-07 Impact factor: 3.633
Authors: Jennifer B Reese; Kristen A Sorice; Whitney Pollard; Elizabeth Handorf; Mary C Beach; Mary B Daly; Laura S Porter; James A Tulsky; Stephen J Lepore Journal: Psychooncology Date: 2020-12-23 Impact factor: 3.894